Rika Nishikawa

Narashino, 2758580, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

Repeated spontaneous migration of ureteral stent in hemiplegia patient during ureteral stone treatment.

Repeated spontaneous migration of ureteral stent in hemiplegia patient during ureteral stone treatment.

Journal: Urology case reports

Published: November 30, 2018

Regulation of HMGB3 by antitumor miR-205-5p inhibits cancer cell aggressiveness and is involved in prostate cancer pathogenesis.

Regulation of HMGB3 by antitumor miR-205-5p inhibits cancer cell aggressiveness and is involved in prostate cancer pathogenesis.

Journal: Journal of human genetics

Published: September 11, 2017

Comparison of the Conventional Centrifuged and Filtrated Preparations in Urine Cytology

Comparison of the Conventional Centrifuged and Filtrated Preparations in Urine Cytology

Journal: Hinyokika kiyo. Acta urologica Japonica

Published: May 03, 2016

Regulation of metastasis-promoting LOXL2 gene expression by antitumor microRNAs in prostate cancer.

Regulation of metastasis-promoting LOXL2 gene expression by antitumor microRNAs in prostate cancer.

Journal: Journal of human genetics

Published: April 02, 2016

Regulation of the collagen cross-linking enzymes LOXL2 and PLOD2 by tumor-suppressive microRNA-26a/b in renal cell carcinoma.

Regulation of the collagen cross-linking enzymes LOXL2 and PLOD2 by tumor-suppressive microRNA-26a/b in renal cell carcinoma.

Journal: International journal of oncology

Published: January 25, 2016

Tumor-suppressive microRNA-29 family inhibits cancer cell migration and invasion directly targeting LOXL2 in lung squamous cell carcinoma.

Tumor-suppressive microRNA-29 family inhibits cancer cell migration and invasion directly targeting LOXL2 in lung squamous cell carcinoma.

Journal: International journal of oncology

Published: September 28, 2015

Tumor-suppressive microRNAs (miR-26a/b, miR-29a/b/c and miR-218) concertedly suppressed metastasis-promoting LOXL2 in head and neck squamous cell carcinoma.

Tumor-suppressive microRNAs (miR-26a/b, miR-29a/b/c and miR-218) concertedly suppressed metastasis-promoting LOXL2 in head and neck squamous cell carcinoma.

Journal: Journal of human genetics

Published: August 27, 2015

Tumor-suppressive microRNA-223 inhibits cancer cell migration and invasion by targeting ITGA3/ITGB1 signaling in prostate cancer.

Tumor-suppressive microRNA-223 inhibits cancer cell migration and invasion by targeting ITGA3/ITGB1 signaling in prostate cancer.

Journal: Cancer science

Published: June 05, 2015

Apparent diffusion coefficient value for estimating clinicohistological factors in bladder cancer including infiltration style and lymphatic invasion.

Apparent diffusion coefficient value for estimating clinicohistological factors in bladder cancer including infiltration style and lymphatic invasion.

Journal: SpringerPlus

Published: May 22, 2015

MicroRNA-26a/b directly regulate La-related protein 1 and inhibit cancer cell invasion in prostate cancer.

MicroRNA-26a/b directly regulate La-related protein 1 and inhibit cancer cell invasion in prostate cancer.

Journal: International journal of oncology

Published: April 27, 2015

Tumour-suppressive microRNA-29s directly regulate LOXL2 expression and inhibit cancer cell migration and invasion in renal cell carcinoma.

Tumour-suppressive microRNA-29s directly regulate LOXL2 expression and inhibit cancer cell migration and invasion in renal cell carcinoma.

Journal: FEBS letters

Published: February 24, 2015

The tumor-suppressive microRNA-1/133a cluster targets PDE7A and inhibits cancer cell migration and invasion in endometrial cancer.

The tumor-suppressive microRNA-1/133a cluster targets PDE7A and inhibits cancer cell migration and invasion in endometrial cancer.

Journal: International journal of oncology

Published: February 20, 2015

Showing 1-12 of 25

Last Updated: 09/26/2026